img

SOLACI 2012

Día por día, todas las presentaciones del último Congreso SOLACI in partnership with TCT, que se llevó a cabo en México DF entre el 8 y 10 de Agosto de 2012.Recorra las imágenes del congreso en esta galería

SOLACI-SOCIME 2012 Día 2

Results of a Multiple Imaging Method Evaluation of the Bioabsorbable Emerolimus-eluting Coronary Stent System (ABSORB)
Hector M. Garcia-Garcia 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Latest Clinical Performance Evidence of Bioabsorbable Coronary Stents
Alexandre Abizaid 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

BVS for Below the Knee
Rebecca Moreira 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Late and Very Late Stent Thrombosis: Differences in Presentation and Outcome that are Germane to Management Decisions
Feres Fausto 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Contemporary Strategies for the Prevention and Management of Stent Thrombosis
Julio Lopez Cuellar 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Patient Characteristics and PCI Strategies: How They Impinge on the Current Incidence of Coronary Restenosis
José Luis Leiva Pons 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

CABG or PCI? What the Interventionalist Should Convey to the Attending Physician to Enable a Propitious Decision
Jorge Gaspar 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Post Stent Antithrombotic Management of the Patient on Oral Anticoagulation: Disentangling a Trouble-prone Situation
Mario A. Benavides 2012-08-08 ...

SOLACI-SOCIME 2012

What Methods Have a Confirmed Efficacy for the Prevention of Contrast Induced Nephropathy?
Ricardo Lluberas 2012-08-08 ...

SOLACI-SOCIME 2012

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management
Marjeta Zorc 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Design and Bioresorbable Characteristics of the Clinically Available Absorb Stent, Plus Expected Developments for the Near Future
Rebecca Moreira 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Which Antiplatelet Therapy for Which Patient? 
Thomas Cuisset 2012-08-08 ...

SOLACI-SOCIME 2012

Timing and Results of Invasive Management
Niemela Kari 2012-08-08 ...

SOLACI-SOCIME 2012

How would I treat 2
Niemelä Kari 2012-08-08 ...

SOLACI-SOCIME 2012

Interventional Cardiology in Latin America 20 Years After the Founding of SOLACI
Marco Martínez Ríos 2012-08-08 ...

SOLACI-SOCIME 2012

Now that We Have Choices, which Antiplatelet Drug (and dosage) Is Preferred Prior to PCI in the Elective, the Ad Hoc and the ACS Patient?
Alejandro Martínez Sepúlveda 2012-08-08 ...

SOLACI-SOCIME 2012

High-dose Statin to Prevent Peri-procedural Myocardial Injury: Current Suggestions Based on Updated Evidence
Daniel Piñeiro 2012-08-08 ...

SOLACI-SOCIME 2012

Bare Metal Stents: Will Their Lower Thrombosis Advantage over DES Vanish Against the CoCr-Everolimus Eluting Stents? 
Armando Tellez 2012-08-08 ...

SOLACI-SOCIME 2012

Update on the Current Status of the Enduring Drug Eluting Stents.
Alexandre Abizaid 2012-08-08 ...

SOLACI-SOCIME 2012

The 4th Revolution in Interventional Cardiology: from Metallic to Polymeric Devices
Eberhard Grube 2012-08-08 ...

SOLACI-SOCIME 2012

meriT-4 BioMime Vs Xience V & Meril FutureCardiovascular. Pipeline
 Abizaid, Alexandre 2012-08-08 ...

SOLACI-SOCIME 2012 Día 2

Drug Eluting Balloon for the Side Branch in Provisional Stent Strategy: Rationale and Current Evidence
Jorge Mor Dale 2012-08-09 ...

SOLACI-SOCIME 2012 Día 2

Bifurcation-Dedicated Stents: an Description of the Clinically Available Devices and of their Performance
Costa, Ricardo 2012-08-09 ...

SOLACI-SOCIME 2012 Día 2

Strategies for Switching Antiplatelet Treatment Regimens in the Setting of ACS, and Its Implications
Hugo Ricardo Hernández García 2012-08-09 ...

SOLACI-SOCIME 2012 Día 2

Mechanical Thrombectomy with the AngioJet Device in AMI with a Glimpse of Other Described Applications
Juan F. Granada 2012-08-09 ...

SOLACI-SOCIME 2012

IVUS or FFR Guided in MV Disease and ACS?
Costantino R. Costantini 2012-08-09 ...

SOLACI-SOCIME 2012

Epidemiologic Characteristics of Arterial Hypertension in Latin American Countries
Jorge Oseguera Moguel 2012-08-09 ...

SOLACI-SOCIME 2012

Anatomy & Physiology of the Renal Sympathetic Nervous System and its Role in Blood Pressure Regulation and in Hypertension
Hugo R. Hernández García 2012-08-09 ...

SOLACI-SOCIME 2012

Supervised Exercise Compared with Revascularization Procedures to Treat Claudication: What
Hermes Ilarraza Lomelí 2012-08-09 ...

SOLACI-SOCIME 2012

Advances in Endovascular Repair of Aortoiliac Occlusive Disease
León Valdivieso 2012-08-09 ...

SOLACI-SOCIME 2012

Sizing the Annulus: Understanding the New Challenges for Optimal Result
Luiz Antonio Carvalho 2012-08-09 ...

SOLACI-SOCIME 2012

TAVI in Degenerated Valves 
Antonio Dager Gómez 2012-08-09 ...

SOLACI-SOCIME 2012

Issues in interventional cardiology: scientirc evidence and real cases from the daily practice
Mauricio de Rezende Barbosa 2012-08-09 ...

SOLACI-SOCIME 2012

Efficacy of intracoronary IIb/IIIa inhibitor during primary PCI. Standard use or bailout only?
Costantino R. Costantini 2012-08-09 ...

SOLACI-SOCIME 2012

Complications of Radial Access and Their Management
Ricardo Lluberas 2012-08-09 ...

SOLACI-SOCIME 2012

Use of IVUS
Steven Baily 2012-08-09 ...

SOLACI-SOCIME 2012

IVUS in Coronary Bifurcations: is it Underused?
Alfonso Medina 2012-08-09 ...

SOLACI-SOCIME 2012

Grounds for Confidence: A Critical Analysis of the Outcomes of Cohorts A and B of the PARTNER Trial 
Rodes Cabau 2012-08-09 ...

SOLACI-SOCIME 2012

TAVR and Atrioventricular Conduction Abnormalities: Incidence, Etiology, Predictors and Improvements
Antonio Dager ...

SOLACI-SOCIME 2012

The Approved Use of Actual DES in Complex Subgroups: Diabetics, ISR, Bifurcation
J. Belardi 2012-08-09 ...

SOLACI-SOCIME 2012

Renal Denervation .The Results of the Simplycity Trials; Long Term Follow Up 
Horst Sievert 2012-08-09 ...

SOLACI-SOCIME 2012

The Role of DEB in Vessel Patency in BTK 
Lewis Carrasquero 2012-08-09 ...

SOLACI-SOCIME 2012

Emerging Bioabsorbable Stent and Balloon Platforms: Are the days of metallic drug-eluting stents numbered? 
Juan F. Granada 2012-08-09 ...

SOLACI-SOCIME 2012

The Road to 1000 Implants in Latina America and a Glimpse into the Future
Eberhard Grube 2012-08-09 ...

SOLACI-SOCIME 2012

An Assortment of Technical Tips for LM Bifurcation Intervention
Guering Eid Lidt 2012-08-10 ...

SOLACI-SOCIME 2012

Left Main Disease Revascularization. The Position of New European and U.S. Guidelines and how it is Performed in Different Geographical Regions
Thomas Cuisset 2012-08-10 ...

SOLACI-SOCIME 2012

CABG vs. PCI for LM Disease: do we Need a New Randomized Trial?. The Rationale for EXCEL Trial
Alfredo E. Rodriguez 2012-08-10 ...

SOLACI-SOCIME 2012

SYNTAX Dictum:
Alejandro Alcocer Chauvet 2012-08-10 ...

SOLACI-SOCIME 2012

Best DES for the Patient with Diabetes: Tough Call or Clear-Cut Decision? An Answer Based on Recent Randomized Trials Results
Halac Marcelo 2012-08-10 ...

SOLACI-SOCIME 2012

Prediction of Restenosis After PCI with Contemporary Drug-Eluting Stents
Ashok Seth 2012-08-10 ...

SOLACI-SOCIME 2012

A Rational Approach to Stent Selection in Patients with STEMI
Alfredo E. Rodriguez 2012-08-10 ...

[nggallery id="7" images="1000000" ]
Top